AAN: Tavapadon as Adjunct to Levodopa Ups Daily ON Time in Parkinson Disease
Significant reduction also seen in change from baseline in daily OFF times versus placebo
Semaglutide Ups Risk for Nonarteritic Anterior Ischemic Optic Neuropathy in Diabetes
Semaglutide use associated with increased risk for NAION at the two-, three-, and four-year time point from the index date
Federal Funding Cuts Would ‘Decimate’ Medical Research, Expert Warns
Biden Plan to Expand Obesity Drug Coverage Is Rejected
Rates of Dissatisfaction High for Hidradenitis Suppurativa Care
74 percent of respondents unaware of FDA-approved treatments; 56 percent said these options had not been discussed by clinician
ACP: Switching From Dulaglutide to Tirzepatide Improves HbA1c Reduction in T2DM
Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide
Alteplase Increases Frequency of Functional Independence After Posterior Circulation Stroke
Findings seen in patients with posterior circulation stroke and with no planned thrombectomy who received alteplase 4.5 to 24 hours after stroke onset
FDA Delays Final Approval of Novavax COVID Vaccine
Rise in Prevalence of Obesity in Youth, Adults With T1DM Seen From 2008 to...
GLP-1 receptor agonist prescriptions increased significantly during study period across all categories of BMI, in dose-response manner
Zoster Vaccine Has Dementia-Preventing or Delaying Effect
Receipt of zoster vaccine reduces probability of new dementia diagnosis over seven-year period by 3.5 percentage points
